Showing results (351-360 of 554) with videos related to

Sort By:
Pageof 56
NPJ Precision Oncology|November 3, 2022
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancerXiaolei Shi, Abderrahman Day, Hannah E Bergom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2018
Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall SurvivalEmmanuel S Antonarakis, Eric J Small, Daniel P Petrylak, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Science Translational Medicine|January 9, 2015
Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical studyMichael T Schweizer, Emmanuel S Antonarakis, Hao Wang, et al.
European Urology|October 9, 2018
Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene DefectsPedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, et al.
The Prostate|January 29, 2026
Phase II Randomized Study of MK-2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG-ACRIN E2809)Anna C Ferrari, Yu-Hui Chen, Ronald Rodríguez, et al.
Investigational New Drugs|February 7, 2019
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancerDeaglan McHugh, Mario Eisenberger, Elisabeth I Heath, et al.
Journal of Extracellular Vesicles|October 9, 2025
Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular SubtypesMegan L Ludwig, Ali T Arafa, Saasha Vinoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerUmang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Pageof 56